Pro Medicus Ltd (ASX:PME)
A$ 204.63 3.92 (1.95%) Market Cap: 21.38 Bil Enterprise Value: 21.23 Bil PE Ratio: 258.70 PB Ratio: 113.81 GF Score: 86/100

Half Year 2022 Pro Medicus Ltd Earnings Call Transcript

Feb 16, 2022 / 12:00AM GMT
Release Date Price: A$48 (+3.60%)
Operator

Thank you for standing by, and welcome to the Pro Medicus PME Half Year Results Briefing. (Operator Instructions) I would now like to hand the conference over to Dr. Sam Hupert, CEO. Please go ahead.

Sam Aaron Hupert
Pro Medicus Limited - Co-Founder, CEO, MD & Executive Director

Thanks very much, and good morning. Thanks, everybody, for joining us. For those that are new to us, we're a medical IT company that specializes in enterprise imaging and radiology information systems. We work in 3 jurisdictions: Melbourne, our home office; Berlin, our largest R&D center; and San Diego, the U.S., our largest market. We're very heavily engineering and R&D focused, and the majority or the bulk of our staff work in the engineering and technology part of our business.

In terms of our product set, we have 2 core products: Visage RIS, which was the product we originally developed here in Australia. It does more the commercial side of radiology, the billing, scheduling interface to Medicare and payers; and Visage 7, which is the clinical product, which is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot